01 7GlaxoSmithKline Inc.
01 12143845
02 12157932
03 12202090
04 12347099
05 12443214
06 12510457
07 12732436
01 7Human Papillomavirus (HPV) type 16 L1 protein | Human Papillomavirus (HPV) type 18 L1 protein
01 7Suspension for Injection
01 12013-09-03
02 12014-03-08
03 12015-10-09
04 12019-10-08
05 12020-09-07
06 12023-12-18
07 12029-07-29
Patent Expiration Date : 2013-09-03
Date Granted : 2003-11-18
Human Papillomavirus (HPV) type 16 L1 protein, Human Papillomavirus (HPV) type 18 L1 protein
Brand Name : CERVARIX
Patent Number : 2143845
Filing Date : 1993-09-03
Strength per Unit : 20 ?g / 0.5 mL; 20 ?g / 0.5 mL
Dosage Form : Suspension for Injection
Human Or VET : Human
Route of Administration : Intramuscular Injection
Patent Expiration Date : 2013-09-03
Date Granted : 2003-11-18
Patent Expiration Date : 2020-09-07
Date Granted : 2006-03-21
Human Papillomavirus (HPV) type 16 L1 protein, Human Papillomavirus (HPV) type 18 L1 protein
Brand Name : CERVARIX
Patent Number : 2443214
Filing Date : 2000-09-07
Strength per Unit : 20 ?g / 0.5 mL; 20 ?g / 0.5 mL
Dosage Form : Suspension for Injection
Human Or VET : Human
Route of Administration : Intramuscular Injection
Patent Expiration Date : 2020-09-07
Date Granted : 2006-03-21
Patent Expiration Date : 2015-10-09
Date Granted : 2012-04-17
Human Papillomavirus (HPV) type 16 L1 protein, Human Papillomavirus (HPV) type 18 L1 protein
Brand Name : CERVARIX
Patent Number : 2202090
Filing Date : 1995-10-09
Strength per Unit : 20 ?g / 0.5 mL; 20 ?g / 0.5 mL
Dosage Form : Suspension for Injection
Human Or VET : Human
Route of Administration : Intramuscular Injection
Patent Expiration Date : 2015-10-09
Date Granted : 2012-04-17
Patent Expiration Date : 2023-12-18
Date Granted : 2011-12-06
Human Papillomavirus (HPV) type 16 L1 protein, Human Papillomavirus (HPV) type 18 L1 protein
Brand Name : CERVARIX
Patent Number : 2510457
Filing Date : 2003-12-18
Strength per Unit : 20 ?g / 0.5 mL; 20 ?g / 0.5 mL
Dosage Form : Suspension for Injection
Human Or VET : Human
Route of Administration : Intramuscular Injection
Patent Expiration Date : 2023-12-18
Date Granted : 2011-12-06
Patent Expiration Date : 2014-03-08
Date Granted : 2011-10-11
Human Papillomavirus (HPV) type 16 L1 protein, Human Papillomavirus (HPV) type 18 L1 protein
Brand Name : CERVARIX
Patent Number : 2157932
Filing Date : 1994-03-08
Strength per Unit : 20 ?g / 0.5 mL; 20 ?g / 0.5 mL
Dosage Form : Suspension for Injection
Human Or VET : Human
Route of Administration : Intramuscular Injection
Patent Expiration Date : 2014-03-08
Date Granted : 2011-10-11
Patent Expiration Date : 2019-10-08
Date Granted : 2014-08-05
Human Papillomavirus (HPV) type 16 L1 protein, Human Papillomavirus (HPV) type 18 L1 protein
Brand Name : CERVARIX
Patent Number : 2347099
Filing Date : 1999-10-08
Strength per Unit : 20 ?g / 0.5 mL; 20 ?g / 0.5 mL
Dosage Form : Suspension for Injection
Human Or VET : Human
Route of Administration : Intramuscular Injection
Patent Expiration Date : 2019-10-08
Date Granted : 2014-08-05
Patent Expiration Date : 2029-07-29
Date Granted : 2018-01-16
Human Papillomavirus (HPV) type 16 L1 protein, Human Papillomavirus (HPV) type 18 L1 protein
Brand Name : CERVARIX
Patent Number : 2732436
Filing Date : 2009-07-29
Strength per Unit : 20 ?g / 0.5 mL; 20 ?g / 0.5 mL
Dosage Form : Suspension for Injection
Human Or VET : Human
Route of Administration : Intramuscular Injection
Patent Expiration Date : 2029-07-29
Date Granted : 2018-01-16
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
